Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-01

Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind study of pregabalin versus placebo in fibromyalgia completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2012-06-01